It’s not a change of topic - it’s a sign that the company was not bluffing when I asked them in October last year as to progress on potency assay work for back and heart, given the horror they were going through with aGVHD. The answer I got then was that the work with CLBP was a lot more advanced than for heart (for the obvious reason that they were then preparing for the back trial to commence).
So I took the patent application on method of treating progressive heart failure which first appeared here a few months ago in someone’s post, as a sign of progress.
Hope this answers your comment.
once approved, page-47
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.010(0.86%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.17 | $1.15 | $506.6K | 437.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 34793 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 28712 | 4 |
View Market Depth
| Last trade - 10.24am 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |